Logo image of PTLA

Portola Pharma (PTLA) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:PTLA -

18.03
+0.04 (+0.22%)
Last: 7/1/2020, 8:13:07 PM
18.02
-0.01 (-0.06%)
After Hours: 7/1/2020, 8:13:07 PM

PTLA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.42B
Revenue(TTM)120.86M
Net Income(TTM)-281.28M
Shares78.48M
Float44.71M
52 Week High31.73
52 Week Low5.31
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-3.72
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


PTLA short term performance overview.The bars show the price performance of PTLA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150

PTLA long term performance overview.The bars show the price performance of PTLA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of PTLA is 18.03 null. In the past month the price increased by 0.56%. In the past year, price decreased by -31.65%.

Portola Pharma / PTLA Daily stock chart

PTLA Latest News, Press Relases and Analysis

2 years ago - By: Bloomberg - Mentions: ALXN
News Image
5 years ago - By: Seeking Alpha - Mentions: ALXN
News Image
5 years ago - By: Barron's - Mentions: TIF MS ETFC ERI ...
News Image
6 years ago - By: Halper Sadeh LLP - Mentions: MINI WLTW
News Image
6 years ago - By: Halper Sadeh LLP - Mentions: TORC KLXE
News Image
6 years ago - By: BusinessInsider
News Image
6 years ago - By: Portola Pharmaceuticals, Inc.®
News Image
6 years ago - By: Halper Sadeh LLP - Mentions: STML KLXE
News Image

About PTLA

Company Profile

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.

Company Info

Portola Pharma

270 EAST GRAND AVENUE

SOUTH SAN FRANCISCO CA 94080

CEO: Scott Garland

Phone: 650-246-7000

Portola Pharma / PTLA FAQ

What does PTLA do?

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.


What is the stock price of Portola Pharma today?

The current stock price of PTLA is 18.03 null. The price increased by 0.22% in the last trading session.


What is the dividend status of Portola Pharma?

PTLA does not pay a dividend.


What is the ChartMill rating of Portola Pharma stock?

PTLA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


PTLA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to PTLA. When comparing the yearly performance of all stocks, PTLA is one of the better performing stocks in the market, outperforming 94.88% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PTLA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PTLA. PTLA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PTLA Financial Highlights

Over the last trailing twelve months PTLA reported a non-GAAP Earnings per Share(EPS) of -3.72. The EPS increased by 21.68% compared to the year before.


Industry RankSector Rank
PM (TTM) -232.73%
ROA -54.8%
ROE N/A
Debt/Equity 4.77
Chartmill High Growth Momentum
EPS Q2Q%13.73%
Sales Q2Q%19.04%
EPS 1Y (TTM)21.68%
Revenue 1Y (TTM)117.16%

PTLA Forecast & Estimates


Analysts
Analysts88
Price TargetN/A
EPS Next Y39.41%
Revenue Next YearN/A

PTLA Ownership

Ownership
Inst Owners98.68%
Ins Owners5.95%
Short Float %N/A
Short RatioN/A